Ida Pavese

GHT Grand Paris Nord Est
Montfermeil, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.

Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.

Journal: Cancers
Published: December 28, 2021

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.

Journal: Frontiers in oncology
Published: June 22, 2020

Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms.

Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms.

Journal: JAMA oncology
Published: March 02, 2018

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study.

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study.

Journal: Oncotarget
Published: April 27, 2017

Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care).

Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care).

Journal: Tumori
Published: November 17, 2016

Patients with delirium and advanced solid cancer in the emergency department: A challenge for the emergency practitioner, oncologist, and intensivist.

Patients with delirium and advanced solid cancer in the emergency department: A challenge for the emergency practitioner, oncologist, and intensivist.

Journal: Cancer
Published: August 17, 2016

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.

Journal: PloS one
Published: February 17, 2016

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.

Journal: PloS one
Published: January 21, 2016

Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey.

Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey.

Journal: Journal of Cancer
Published: December 08, 2015

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).

Journal: Scientific reports
Published: April 22, 2015

Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study.

Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study.

Journal: World journal of gastroenterology
Published: January 06, 2015

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

Journal: Neoplasia (New York, N.Y.)
Published: May 21, 2014
Showing 1-12 of 17

Last Updated: 09/26/2026